Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin vs Atorvastatin in Metabolic Syndrome
NCT00654485Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- May 2002
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of rosuvastatin in metabolic syndrome, sponsored by AstraZeneca. Started May 2002; status: completed.
02
Drugs
rosuvastatin
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT00654485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00654485.